Clinical Chemistry, Karolinska University Hospital, Molecular Medicine & Surgery, Karolinska Institutet L7:00, 171 76 Stockholm, Sweden.
Institute for Immunology and Transfusion Medicine, Universitätsmedizin Greifswald Ernst-Moritz-Arndt University Greifswald, Klinikum Sauerbruckstrasse, 17487 Greifswald, Germany.
Thromb Res. 2017 Apr;152:77-81. doi: 10.1016/j.thromres.2017.02.015. Epub 2017 Feb 24.
Heparin-Induced Thrombocytopenia (HIT) is a rare but serious immune-mediated complication of heparin treatment. HIT is characterized by an acute, transient prothrombotic state combined with thrombocytopenia and is caused by platelet-activating IgG antibodies that bind to complexes of heparin and platelet factor 4. The diagnosis of HIT relies on clinical presentation and the demonstration of HIT antibodies. One approach to improve the efficacy of laboratory analysis is to use a diagnostic algorithm.
To evaluate one diagnostic algorithm for HIT where the 4 T's clinical risk score is combined with immunochemical and/or functional assays.
The quality of the diagnostic algorithm was retrospectively evaluated in 101 patients with suspected HIT. Laboratory results obtained from the diagnostic algorithm were compared to Heparin-Induced Platelet Aggregation (HIPA) and clinico-pathological evaluation of patients' medical records.
We found that the algorithm had a diagnostic efficacy of 94%, with specificity of 94% and sensitivity 94%. Positive likelihood ratio (LR+) was 16.0, and the negative likelihood ratio (LR-) 15.5. The efficacy of PaGIA (n=95) was 0.46, and IgG-specific HPF4-abELISA (n=54) was 0.87.
The diagnostic algorithm for HIT is sufficiently accurate and leads to in overall faster results and decreased cost of analysis. The weakest link of the algorithm is the risk of miscalculated 4T's scores, which is inevitably exacerbated by the insufficient experience most clinicians have with HIT. This highlights the importance of clear instructions from the laboratory and coagulation clinic.
肝素诱导的血小板减少症(HIT)是肝素治疗中一种罕见但严重的免疫介导的并发症。HIT 的特征是急性、短暂的促血栓形成状态,伴有血小板减少症,是由与肝素和血小板因子 4 复合物结合的血小板激活 IgG 抗体引起的。HIT 的诊断依赖于临床表现和 HIT 抗体的检测。提高实验室分析效果的一种方法是使用诊断算法。
评估一种将 4T's 临床风险评分与免疫化学和/或功能检测相结合的 HIT 诊断算法。
回顾性评估了 101 例疑似 HIT 患者的诊断算法的质量。从诊断算法中获得的实验室结果与肝素诱导的血小板聚集(HIPA)和对患者病历的临床病理评估进行了比较。
我们发现该算法的诊断效能为 94%,特异性为 94%,敏感性为 94%。阳性似然比(LR+)为 16.0,阴性似然比(LR-)为 15.5。PaGIA(n=95)的效能为 0.46,IgG 特异性 HPF4-abELISA(n=54)的效能为 0.87。
HIT 的诊断算法足够准确,总体上可以更快地得到结果,并降低分析成本。算法的薄弱环节是 4T's 评分计算错误的风险,这不可避免地因大多数临床医生对 HIT 的经验不足而加剧。这凸显了实验室和凝血科提供明确说明的重要性。